Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2022/03/040816
CTRI/2022/03/040816CompletedNot Applicable

Assessment of Quality of life in follow-up patients with COVID-19 pneumonia

IMS SUM hospital1 site in 1 country70 target enrollmentStarted: March 14, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
70
Locations
1
Primary Endpoint
Assessment of quality of life using SF-12 scale in COVID-19 pneumonia follow-up patients
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Adult patients more than 18 years after discharge with diagnosis  of  COVID pneumonia, will be assessed about their quality of life with telephonic interview 6 months after discharge. Assessment of quality of life will be done using SF-12 scale in COVID-19 pneumonia follow-up patients. Patients who have died while during follow up at 6 months, obviously their quality of life can not be assessed which is the primary outcome. But their data and records will be kept

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Inclusion criteria 1.Patients aged more than or equal to 18 years 2.Patients discharged with diagnosis of COVID-19 pneumonia.

Exclusion Criteria

  • •not willing to disclose their quality of life.

Outcomes

Primary Outcomes

Assessment of quality of life using SF-12 scale in COVID-19 pneumonia follow-up patients

Time Frame: 3 months, 6 months, 12 months

Secondary Outcomes

  • mortality rate after discharge(3month 6month 12 months)

Investigators

Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
A study to understand post COVID quality of life
CTRI/2021/01/030573Medanta Institute of Education and Research5,000
Completed
Not Applicable
Quality of life after covid infection , A followup study
CTRI/2022/03/040816IMS SUM hospital225
Unknown
Not Applicable
COVID-19 - Quality of Life After InfectionCOVID-19Quality of Life
NCT04377464Chinese University of Hong Kong200
Withdrawn
Not Applicable
Quality of Life Following ECMOExtracorporeal Membrane OxygenationQuality of Life
NCT02809703Duke University
Completed
Phase 1
Extension Study in a Cohort of Adult Patients With COVID-19 InfectionCOVID-19 Infection
NCT05121740PharmaMar34